A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome
Introduction: Coronavirus disease 2019 (COVID-19) can have symptoms like many neurological diseases, and one of the rare forms of these presentations is opsoclonus-myoclonus ataxia syndrome (OMAS). The pathogenesis of OMAS in adults has not been clearly elucidated and OMAS can be fatal. Case pres...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2024-02-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/17927 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850193187848585216 |
|---|---|
| author | Adalet Altunsoy Nizamettin Kemirtlek Halime Araz Ebru Bilge Dirik Esragül Akıncı |
| author_facet | Adalet Altunsoy Nizamettin Kemirtlek Halime Araz Ebru Bilge Dirik Esragül Akıncı |
| author_sort | Adalet Altunsoy |
| collection | DOAJ |
| description |
Introduction: Coronavirus disease 2019 (COVID-19) can have symptoms like many neurological diseases, and one of the rare forms of these presentations is opsoclonus-myoclonus ataxia syndrome (OMAS). The pathogenesis of OMAS in adults has not been clearly elucidated and OMAS can be fatal.
Case presentation: We present a 71-year-old male patient who was admitted to the emergency department with complaints of involuntary tremor-like movements in his hands, feet and mouth, and speech impediment for three days, and was followed up with COVID-19. The patient was diagnosed with OMAS and clonazepam treatment was started. He died three days later due to respiratory arrest. Our case is the first case diagnosed with COVID-19-associated OMAS in Turkey.
Discussion: OMAS has no definitive treatment. Early diagnosis and initiation of corticosteroids and intravenous immunoglobulin (IVIG) therapy, if necessary, can be life-saving. In COVID-19 patients with unexplained clinical findings, awareness of different and rare diseases and a multidisciplinary approach has vital importance.
|
| format | Article |
| id | doaj-art-1f8c062ca9024ec6ab5e2a4cfb431b25 |
| institution | OA Journals |
| issn | 1972-2680 |
| language | English |
| publishDate | 2024-02-01 |
| publisher | The Journal of Infection in Developing Countries |
| record_format | Article |
| series | Journal of Infection in Developing Countries |
| spelling | doaj-art-1f8c062ca9024ec6ab5e2a4cfb431b252025-08-20T02:14:20ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802024-02-01180210.3855/jidc.17927A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndromeAdalet Altunsoy0Nizamettin Kemirtlek1Halime Araz2Ebru Bilge Dirik3Esragül Akıncı4University of Health Sciences, Gulhane Medical School, Ankara, TurkeyDepartment of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara, TurkeyDepartment of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara, TurkeyDepartment of Neurology, Ankara City Hospital, TurkeyUniversity of Health Sciences, Gulhane Medical School, Ankara, Turkey Introduction: Coronavirus disease 2019 (COVID-19) can have symptoms like many neurological diseases, and one of the rare forms of these presentations is opsoclonus-myoclonus ataxia syndrome (OMAS). The pathogenesis of OMAS in adults has not been clearly elucidated and OMAS can be fatal. Case presentation: We present a 71-year-old male patient who was admitted to the emergency department with complaints of involuntary tremor-like movements in his hands, feet and mouth, and speech impediment for three days, and was followed up with COVID-19. The patient was diagnosed with OMAS and clonazepam treatment was started. He died three days later due to respiratory arrest. Our case is the first case diagnosed with COVID-19-associated OMAS in Turkey. Discussion: OMAS has no definitive treatment. Early diagnosis and initiation of corticosteroids and intravenous immunoglobulin (IVIG) therapy, if necessary, can be life-saving. In COVID-19 patients with unexplained clinical findings, awareness of different and rare diseases and a multidisciplinary approach has vital importance. https://jidc.org/index.php/journal/article/view/17927COVID-19opsoclonus-myoclonus ataxia syndromecorticosteroidsintravenous immunoglobulinIVIG |
| spellingShingle | Adalet Altunsoy Nizamettin Kemirtlek Halime Araz Ebru Bilge Dirik Esragül Akıncı A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome Journal of Infection in Developing Countries COVID-19 opsoclonus-myoclonus ataxia syndrome corticosteroids intravenous immunoglobulin IVIG |
| title | A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome |
| title_full | A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome |
| title_fullStr | A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome |
| title_full_unstemmed | A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome |
| title_short | A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome |
| title_sort | rare clinical presentation of covid 19 opsoclonus myoclonus ataxia syndrome |
| topic | COVID-19 opsoclonus-myoclonus ataxia syndrome corticosteroids intravenous immunoglobulin IVIG |
| url | https://jidc.org/index.php/journal/article/view/17927 |
| work_keys_str_mv | AT adaletaltunsoy arareclinicalpresentationofcovid19opsoclonusmyoclonusataxiasyndrome AT nizamettinkemirtlek arareclinicalpresentationofcovid19opsoclonusmyoclonusataxiasyndrome AT halimearaz arareclinicalpresentationofcovid19opsoclonusmyoclonusataxiasyndrome AT ebrubilgedirik arareclinicalpresentationofcovid19opsoclonusmyoclonusataxiasyndrome AT esragulakıncı arareclinicalpresentationofcovid19opsoclonusmyoclonusataxiasyndrome AT adaletaltunsoy rareclinicalpresentationofcovid19opsoclonusmyoclonusataxiasyndrome AT nizamettinkemirtlek rareclinicalpresentationofcovid19opsoclonusmyoclonusataxiasyndrome AT halimearaz rareclinicalpresentationofcovid19opsoclonusmyoclonusataxiasyndrome AT ebrubilgedirik rareclinicalpresentationofcovid19opsoclonusmyoclonusataxiasyndrome AT esragulakıncı rareclinicalpresentationofcovid19opsoclonusmyoclonusataxiasyndrome |